The October 2026 issue of Sanità & Benessere, the Italian health magazine distributed with Il Venerdì di Repubblica and Il Sole 24 Ore, features an in-depth article on Health Triage. In it, Davide Dettori and Guido Cannito present our vision of healthcare innovation. Titled “Digital healthcare: the value of AI is born in clinical practice”…
Guido Cannito, Chief Commercial Officer & Head of Market Development di Health Triage, porta vent’anni di esperienza nell’innovazione sanitaria. Oggi guida il percorso che trasforma ricerca, algoritmi e validazione clinica in soluzioni adottate dai sistemi sanitari. Negli ultimi vent’anni la sanità ha vissuto una trasformazione profonda. Prima è arrivata la digitalizzazione dei processi clinici, poi…
The research, presented at the international MEDICON 2026 congress in Siena and published by Springer Nature, analyses an Artificial Intelligence system for screening mammography. The study, authored by Luca Piano, Domenico Ficili, Giovanni Maimone, Giovanni Serra, Elena Galeasso, Giulia Rotunno, Simone Mazzetti, Valentina Giannini, Daniele Regge and Francesca Caumo, points to a possible 75% reduction…
Raffaele Petrone is Executive Chairman of Petrone Group, an international healthcare group with nearly 2,000 employees and collaborators. He is Chairman of Health Triage, an Italian deep tech company developing artificial intelligence solutions for cancer prevention and diagnostics. Investing in a company that develops artificial intelligence for healthcare means looking beyond technology. It takes clinical…
The company is one of the 84 organizations featured in the volume produced by the Italian Ministry of Foreign Affairs and International Cooperation, with scientific curation by AIRI. Presented at Prix Italia 2026, the project will bring the most significant experiences of AI applied to the real economy to the world through Italy’s diplomatic network.…
The manager’s arrival marks a new growth phase for the company developing Artificial Intelligence solutions for cancer prevention and diagnosis. Turin/Naples, 15 September 2026 — Health Triage announces the appointment of Guido Cannito as its new Chief Commercial Officer & Head of Market Development. With over twenty years of experience in technological innovation applied to…
The operation enables expansion into EU and US markets and the completion of the FDA process for Prostate V-Bio. The integration of new strategic partners consolidates the group’s clinical leadership in high-impact, technology-driven early diagnosis. NAPLES/TURIN, 2 July 2026 – Health Triage S.p.A., an Italian deep-tech company specialising in the development of Artificial Intelligence solutions…
Monday, June 29, 2026, starting at 10:00 AM, the Romantic Hotel Furno in San Francesco al Campo will host the institutional conference “Artificial Intelligence: from radiology to global scenarios”, organized by the Centro Diagnostico Studio Futura of Ciriè and by Health Triage, under the patronage of Confindustria Canavese. The event was born to address an…
Davide Dettori, CEO of Health Triage, is leading the development of AI for oncological diagnostics. From virtual biopsy to precision prevention, his goal is to bring validated technologies into global clinical practice. Bringing artificial intelligence into clinical practice is no longer a promise — it is a concrete challenge that requires scientific rigour, multidisciplinary integration…
Piedmont confirms itself as a national reference point in medical research and innovation applied to cancer prevention. This is demonstrated by the new study on prostate cancer screening, covered by La Stampa in an article by Alessandro Mondo, which aims to gather the scientific evidence needed to build an organised screening programme integrated into the…